Skip to main content
Clinical Trials/DRKS00019221
DRKS00019221
Completed
Phase 3

The efficacy of Cognitive Bias Modification as an add-on in smoking cessation: A randomized-controlled double-blind study - CBM

udwig-Maximilians-Universität München0 sites354 target enrollmentNovember 11, 2019
ConditionsF17.2

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
F17.2
Sponsor
udwig-Maximilians-Universität München
Enrollment
354
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 11, 2019
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
udwig-Maximilians-Universität München

Eligibility Criteria

Inclusion Criteria

  • i. Age 18\-70 years
  • ii. CO \= 10 ppm
  • iii. Fagerstrøm Test for Nicotine Dependence \= 3
  • iv. Consumption of at least 10 cigarettes daily within the last 12 months
  • v. No consumption of nicotine replacement therapy (NRT) and no pharmacological smoking cessation therapry 3 months prior to study participation
  • vi. Willingness to abstain from NRT, e\-cigarettes and any other smoking cessation intervention during study participation
  • vii. Interest to participate in the smokefree program

Exclusion Criteria

  • i. Severe psychiatric disorder (e.g., bipolar disorder, psychosis)
  • ii. Severe neurological disorder (e.g., z.B. Morbus Parkinson, multiple sclerosis)
  • iii. Acute suicidality
  • iv. Moderate substance dependence (\> criteria fulfilled according to DSM\-5; except tobacco)
  • v. Pregnancy or nursing
  • vi. Insufficient knowledge of German language

Outcomes

Primary Outcomes

Not specified

Similar Trials